Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | F11 | P03951 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12130130 | 1.00 | CYP2D6 (0.36) | CYP2D6THRBHSD17B10CA2F11 | |
| SCHEMBL2629586 | 1.00 | CYP2D6 (0.36) | CYP2D6THRBHSD17B10CA2F11 | |
| SCHEMBL10077885 | 0.89 | CYP2D6 (0.33) | CYP2D6THRBHSD17B10CA2LMNA | |
| SCHEMBL16327915 | 0.86 | F11 (0.36) | CYP2D6THRBHSD17B10CA2F11 | |
| SCHEMBL472876 | 0.81 | FGF1 (0.37) | CYP2D6LMNA | |
| SCHEMBL8824639 | 0.76 | CYP2D6 (0.56) | CYP2D6THRBHSD17B10CA2LMNA | |
| SCHEMBL20741877 | 0.76 | CYP2D6 (0.56) | CYP2D6THRBHSD17B10CA2LMNA | |
| SCHEMBL20741964 | 0.76 | CYP2D6 (0.56) | CYP2D6THRBHSD17B10CA2LMNA | |
| SCHEMBL26445366 | 0.76 | CYP2D6 (0.56) | CYP2D6THRBHSD17B10CA2LMNA | |
| SCHEMBL26101291 | 0.76 | CYP2D6 (0.56) | CYP2D6THRBHSD17B10CA2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080214798-A1 | Sugar chain asparagine derivatives, sugar chain asparagine, sugar chain and processes for producing these | OTSUKA CHEMCIAL CO., LTD. (JP) | 2008-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214798-A1 | Sugar chain asparagine derivatives, sugar chain asparagine, sugar chain and processes for producing these | FUT6, B3GNT2, FUT5 | CYP2D6 1866/4885THRB 2097/4885HSD17B10 1519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.